FR2005118A1 - - Google Patents

Info

Publication number
FR2005118A1
FR2005118A1 FR6909437A FR6909437A FR2005118A1 FR 2005118 A1 FR2005118 A1 FR 2005118A1 FR 6909437 A FR6909437 A FR 6909437A FR 6909437 A FR6909437 A FR 6909437A FR 2005118 A1 FR2005118 A1 FR 2005118A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6909437A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2005118A1 publication Critical patent/FR2005118A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR6909437A 1968-03-29 1969-03-28 Withdrawn FR2005118A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1532868A GB1262864A (en) 1968-03-29 1968-03-29 Diazacarbazoles

Publications (1)

Publication Number Publication Date
FR2005118A1 true FR2005118A1 (de) 1969-12-05

Family

ID=10057154

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6909437A Withdrawn FR2005118A1 (de) 1968-03-29 1969-03-28

Country Status (6)

Country Link
CH (1) CH549039A (de)
DE (1) DE1916011A1 (de)
FR (1) FR2005118A1 (de)
GB (1) GB1262864A (de)
IE (1) IE33207B1 (de)
NL (1) NL6904815A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2019812C (en) * 1989-06-28 2000-11-21 Gunther Schmidt (Deceased) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
SG11201404241SA (en) 2012-01-27 2014-08-28 Univ Montreal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
CN110156792A (zh) * 2019-06-28 2019-08-23 广州暨南生物医药研究开发基地有限公司 一种嘧啶并吲哚化合物及其制备方法和应用

Also Published As

Publication number Publication date
NL6904815A (de) 1969-10-01
CH549039A (de) 1974-05-15
GB1262864A (en) 1972-02-09
IE33207L (en) 1969-09-29
IE33207B1 (en) 1974-04-17
DE1916011A1 (de) 1970-03-05

Similar Documents

Publication Publication Date Title
AU1946070A (de)
AU5506869A (de)
AU2374870A (de)
AU5184069A (de)
AU6168869A (de)
AU6171569A (de)
AU416157B2 (de)
AU2581067A (de)
AU4811568A (de)
AU421558B1 (de)
AR203075Q (de)
AU3789668A (de)
AU3224368A (de)
AU2580267A (de)
BE715120A (de)
BE709320A (de)
BE726670A (de)
AU4224469A (de)
BE726334A (de)
BE726230A (de)
BE726193A (de)
BE726062A (de)
BE721617A (de)
BE720851A (de)
BE728384A (de)

Legal Events

Date Code Title Description
ST Notification of lapse